581 related articles for article (PubMed ID: 24903195)
1. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial.
Pöss J; Fuernau G; Denks D; Desch S; Eitel I; de Waha S; Link A; Schuler G; Adams V; Böhm M; Thiele H
Eur J Heart Fail; 2015 Nov; 17(11):1152-60. PubMed ID: 26333723
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
[TBL] [Abstract][Full Text] [Related]
5. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].
Abdin A; Pöss J; Fuernau G; Ouarrak T; Desch S; Eitel I; de Waha S; Zeymer U; Böhm M; Thiele H
Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774
[TBL] [Abstract][Full Text] [Related]
7. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
Fuernau G; Fengler K; Desch S; Eitel I; Neumann FJ; Olbrich HG; de Waha A; de Waha S; Richardt G; Hennersdorf M; Empen K; Hambrecht R; Jung C; Böhm M; Pöss J; Strasser RH; Schneider S; Ouarrak T; Schuler G; Werdan K; Zeymer U; Thiele H
Clin Res Cardiol; 2016 Dec; 105(12):1030-1041. PubMed ID: 27378612
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
9. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
Prondzinsky R; Unverzagt S; Russ M; Lemm H; Swyter M; Wegener N; Buerke U; Raaz U; Ebelt H; Schlitt A; Heinroth K; Haerting J; Werdan K; Buerke M
Shock; 2012 Apr; 37(4):378-84. PubMed ID: 22266974
[TBL] [Abstract][Full Text] [Related]
12. Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.
Jung C; Fuernau G; de Waha S; Eitel I; Desch S; Schuler G; Figulla HR; Thiele H
Clin Res Cardiol; 2015 Aug; 104(8):679-87. PubMed ID: 25720332
[TBL] [Abstract][Full Text] [Related]
13. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
[TBL] [Abstract][Full Text] [Related]
14. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
[TBL] [Abstract][Full Text] [Related]
16. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
[TBL] [Abstract][Full Text] [Related]
18. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
Pöss J; Köster J; Fuernau G; Eitel I; de Waha S; Ouarrak T; Lassus J; Harjola VP; Zeymer U; Thiele H; Desch S
J Am Coll Cardiol; 2017 Apr; 69(15):1913-1920. PubMed ID: 28408020
[TBL] [Abstract][Full Text] [Related]
19. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
[TBL] [Abstract][Full Text] [Related]
20. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
